Strategic Overview of Global Preventable Vaccine Market 2012-2016

Strategic Overview of Global Preventable Vaccine Market 2012-2016

Category : Healthcare

TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

TechNavio's analysts forecast the Strategic Overview of Global Preventable Vaccine Market to grow at a CAGR of 8.99 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in demand for vaccination. The Strategic Overview of Global Preventable Vaccine market has also been witnessing the trend of increase in market consolidation. However, the emergence of regional players could pose a challenge to the growth of this market. 

TechNavio's report, the Strategic Overview of Global Preventable Vaccine Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, and the EMEA and APAC regions; it also covers the Strategic Overview of Global Preventable Vaccine Market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this space include GlaxoSmithKline plc. Sanofi Pasteur SA, Merck & Co. Inc., Novartis AG, Pfizer Inc., Emergent BioSolutions Inc .

Key questions answered in this report:
What will the market size be in 2016 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

01. Executive Summary

02. List of Abbreviations

03. Introduction

04. Market Research Methodology


Market Research Process

Research Design

Research Methodology

05. Scope of the Report

Market Overview

Product Offerings

06. Vaccine

06.1 Introduction

06.2 Types of Vaccines

Live Attenuated (weakened) Vaccine

Killed (inactivated) Vaccine

Toxoid Vaccine

Genetically Modified/Engineered Vaccine

06.3 Subunit Vaccines

06.4 Conjugate Vaccines

06.5 DNA Vaccines

06.6 Recombinant Vector Vaccines

06.7 Vaccine Approval Process

07. Global Preventable Vaccines Market

07.1 Market Size and Forecast

07.2 Global Preventable Vaccine Market Segmentation

07.3 Global Preventable Vaccine Market Share by Vaccine Type 2012

07.4 Global Preventable Vaccine Market by Revenue 2012-2016(US$ billions)

08. Competitive Landscape of Global Preventable Vaccine Market

08.1 Global Preventable Vaccine Market Share by Vendor 2012

08.2 Global Preventable Vaccine Market Share by Vaccine Type 2016

08.3 Global Preventable Vaccine Market Share by Vaccine Type 2012-2016

09. Geographical Analysis of Global Preventable Vaccines Market

09.1 Market Size and Forecast for the US

09.2 Market Size and Forecast for EU

09.3 Market Size and Forecast for Japan

09.4 Market Size and Forecast for India

09.5 Market Size and Forecast for China

09.6 Market Size and Forecast for ROW

10. Global Pediatric Preventable Vaccines Market

10.1 Global Pediatric Preventable Vaccines Market

Market Size and Forecast

10.2 Market Segmentation of Global Pediatric Preventable Vaccine

10.3 Global Pediatric Hepatitis Vaccine Market

Market Size and Forecast

10.4 Global Pediatric Haemophilus Influenzae Type B (Hib) Vaccine Market

Market Size and Forecast

10.5 Global Pediatric Measles, Mumps and Rubella (MMR) Vaccine Market

Market Size and Forecast

10.6 Global Pediatric Combination Vaccines Market

Market Size and Forecast

10.7 Global Pediatric Pneumococcal Vaccine Market

Market Size and Forecast

10.8 Global Polio Vaccine Market

Market Size and Forecast

10.9 Global Pediatric Varicella Vaccine Market

Market Size and Forecast

10.10 Global Other Pediatric Vaccine Market

Market Size and Forecast

10.11 Global Pediatric Preventable Vaccine Market 2012-2016 (Percentage)

11. Pipeline Assessment of Pediatric Preventable Vaccine Market

12. Competitive Landscape of Global Pediatric Preventable Vaccine Market


12.1 Global Pediatric Preventable Vaccine Market Share by Vendor 2012

12.2 Global Pediatric Preventable Vaccine Market Share by Vaccine Type 2012

12.3 Global Pediatric Preventable Vaccine Market Share by Vaccine Type 2016

13. Geographical Segmentation of Pediatric Preventable Vaccine Market

14. Global Pediatric Preventable Vaccines Market by Regions


14.1 Market Size and Forecast for the US

14.2 Market Size and Forecast for EU

14.3 Market Size and Forecast for Japan

14.4 Market Size and Forecast for India

14.5 Market Size and Forecast for China

14.6 Market Size and Forecast for ROW

15. Global Adult Preventable Vaccines Market

15.1 Global Adult Preventable Vaccines Market

Market Size and Forecast

15.2 Market Segmentation of Global Adult Preventable Vaccine

15.3 Global Cervical Vaccine Market

Market Size and Forecast

15.4 Global Hepatitis Vaccine Market

Market Size and Forecast

15.5 Global Influenza Vaccine Market

Market Size and Forecast

15.6 Global Adult Pneumococcal Vaccine Market

Market Size and Forecast

15.7 Global Travel, Diphtheria-Tetanus, Miscellaneous Vaccine Market

Market Size and Forecast

16. Pipeline Assessment of Adult Preventable Vaccine Market

17. Competitive Landscape of Global Adult Preventable Vaccine Market


17.1 Global Adult Preventable Vaccine Market Share by Vendor 2012

17.2 Global Adult Preventable Vaccine Market Share by Vaccine Type 2012

17.3 Global Adult Preventable Vaccine Market Share by Vaccine Type 2016

18. Geographical Segmentation of Adult Preventable Vaccine Market

19. Global Adult Preventable Vaccines Market by Regions


19.1 Market Size and Forecast for US

19.2 Market Size and Forecast for EU

19.3 Market Size and Forecast for Japan

19.4 Market Size and Forecast for India

19.5 Market Size and Forecast for China

19.6 Market Size and Forecast for ROW

20. Buying Criteria

21. Market Growth Drivers

22. Drivers and their Impact

23. Market Challenges

24. Impact of Drivers and Challenges

25. Market Trends

26. Key Vendor Analysis


26.1 Sanofi Pasteur SA

Business Overview

Key Information

SWOT Analysis

26.2 GlaxoSmithKline plc.

Business Overview

Key Information

SWOT Analysis

26.3 Pfizer Inc.

Business Overview

Key Information

SWOT Analysis

26.4 Novartis AG

Business Overview

Key Information

SWOT Analysis

26.5 Merck & Co. Inc.

Business Overview

Key Information

SWOT Analysis

26.6 Emergent BioSolutions Inc.

Business Overview

Key Information

SWOT Analysis

27. Other Reports in this Series





List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Categorization of Global Preventable Vaccine Market

Exhibit 3: Vaccine Approval Process

Exhibit 4: Global Preventable Vaccines Market 2012-2016 (US$ billions)

Exhibit 5: Preventable Vaccines market in US 2012-2016 (US$ billions)

Exhibit 6: Preventable Vaccines market in EU 2012-2016 (US$ billions)

Exhibit 7: Preventable Vaccines market in Japan 2012-2016 (US$ billions)

Exhibit 8: Preventable Vaccines market in India 2012-2016 (US$ billions)

Exhibit 9: Preventable Vaccines market in China 2012-2016 (US$ billions)

Exhibit 10: Preventable Vaccines market in ROW 2012-2016 (US$ billions)

Exhibit 11: Geographical Analysis of Global Preventable Vaccines Market 2012-2016 (US$ billions)

Exhibit 12: Geographical Analysis of Global Preventable Vaccines Market 2012-2016 (CAGR values)

Exhibit 13: Global Pediatric Preventable Vaccines Market 2012-2016 (US$ billions)

Exhibit 14: Global Pediatric Hepatitis Vaccine Market 2012-2016 (US$ billions)

Exhibit 15: Global Pediatric Haemophilus Influenzae Type B Market 2012-2016 (US$ billions)

Exhibit 16: Global Pediatric Measles, Mumps and Rubella (MMR) Vaccine Market 2012-2016 (US$ billions)

Exhibit 17: Global Pediatric Combination Vaccines Market 2012-2016 (US$ billions)

Exhibit 18: Global Pediatric Pneumococcal Vaccine Market 2012-2016 (US$ billions)

Exhibit 19: Global Polio Vaccine Market 2012-2016 (US$ billions)

Exhibit 20: Global Pediatric Varicella Vaccine Market 2012-2016 (US$ billions)

Exhibit 21: Global Other Pediatric Vaccine Market 2012-2016 (US$ billions)

Exhibit 22: Global Pediatric Preventable Vaccine Market by Geographical Segmentation 2012

Exhibit 23: Pediatric Preventable Vaccines market in US 2012-2016 (US$ billions)

Exhibit 24: Pediatric Preventable Vaccines market in EU 2012-2016 (US$ billions)

Exhibit 25: Pediatric Preventable Vaccines market in Japan 2012-2016 (US$ billions)

Exhibit 26: Pediatric Preventable Vaccines market in India 2012-2016 (US$ billions)

Exhibit 27: Pediatric Preventable Vaccines market in China 2012-2016 (US$ billions)

Exhibit 28: Pediatric Preventable Vaccines market in ROW 2012-2016 (US$ billions)

Exhibit 29: Global Adult Preventable Vaccines Market 2012-2016 (US$ billions)

Exhibit 30: Global Cervical Vaccine Market 2012-2016 (US$ billions)

Exhibit 31: Global Hepatitis Vaccine Market 2012-2016 (US$ billions)

Exhibit 32: Global Influenza Vaccine Market 2012-2016 (US$ billions)

Exhibit 33: Global Adult Pneumococcal Vaccine Market 2012-2016 (US$ billions)

Exhibit 34: Global Travel, Diphtheria-Tetanus, Miscellaneous Vaccine Market 2012-2016 (US$ billions)

Exhibit 35: Global Adult Preventable Vaccine Market by Geographical Segmentation 2012

Exhibit 36: Adult Preventable Vaccines market in US 2012-2016 (US$ billions)

Exhibit 37: Adult Preventable Vaccines market in EU 2012-2016 (US$ billions)

Exhibit 38: Adult Preventable Vaccines market in Japan 2012-2016 (US$ billions)

Exhibit 39: Adult Preventable Vaccines market in India 2012-2016 (US$ billions)

Exhibit 40: Adult Preventable Vaccines market in China 2012-2016 (US$ billions)

Exhibit 41: Adult Preventable Vaccines market in ROW 2012-2016 (US$ billions)


Enquiry Before Buy
image
Can´t read the image ? refresh here.